Nicotine (the drug in tobacco that causes addiction) is a powerful drug capable of inducing a variety of pharmacologic effects, including an alteration in brain chemistry, however, tobacco addiction is more than just a brain disease. It’s a complex process involving the interplay of many factors that influence an individual’s decision to use tobacco.
Tobacco use is clearly a complex, addictive behavior and to maximize patients’ chances of successfully quitting, clinicians should advocate behavioral interventions in combination with one or more Food and Drug Administration (FDA)-approved medications for cessation, except in cases where there may be contraindications.
Pharmacotherapies for tobacco dependence are among the most cost-effective in all of medicine and should be considered a first-line treatment. Research shows that both counseling and medicine are effective independently, but the combination is more effective than either alone.
The 2006 Morbidity and Mortality in People with Serious Mental Illness report issued by the National Association of State Mental Health Program Directors, found that people with serious mental illness die, on average, 25 years earlier and suffer increased medical co-morbidity, often from tobacco-related disease. In fact, they are more likely to die from tobacco-related diseases than from alcohol use. These individuals may have more difficulty quitting smoking for a variety of psychological and social reasons, thus the importance to use evidence-based tobacco treatment approaches for this population.
